Drugs / Remegal
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01179854 | Sep 2009 → Nov 2010 | — | Valexfarm | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01749046 | Mar 2012 → Oct 2013 | complex partial epilepsy, simple partial epilepsy | Valexfarm | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Remegal | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01749046 ↗ |
| Known as | Remegal (beprodone) | “Remegal (beprodone)” NCT01179854 ↗ |